Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/1/25 20:59 | 4/29/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Fisher Andrew | X0 | O | GC | 1 | S.d | -234 | 8.98 | 0 | -26 | 360 | D | |||||||||||||||
5/1/25 20:58 | 4/29/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Zaccardelli David | X0 | DO | P,CEO | 10 | S.dm | -12,858 | 4.45 | 0 | -2,890 | 15,851 | D | |||||||||||||||
5/1/25 20:56 | 4/29/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Rickard Kathleen A. | X0 | O | Chief Me | 5 | S.d | -2,299 | 5.39 | 0 | -426 | 2,732 | D | |||||||||||||||
5/1/25 20:55 | 4/29/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Hahn Mark W | X0 | O | CFO | 10 | S.dm | -12,857 | 4.45 | 0 | -2,890 | 14,940 | D | |||||||||||||||
5/1/25 20:53 | 4/29/25 | VRNA | Health | Drug | Pharmaceutical Preparations | Sinha Vikas | X0 | D | 1 | S.d | -178 | 8.92 | 0 | -20 | 74 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |